Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

14/05/2019 07:00

May 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2019        Mar 31, 2018     Dec 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            347 mln             396 mln           2.02     
                 (-12.3 pct)         (-5.1 pct)      (+171.6 pct) 
  Operating     loss 104 mln        loss 240 mln        187 mln   
  Recurring      loss 95 mln        loss 285 mln        195 mln   
  Net           loss 102 mln        loss 311 mln        153 mln   
  EPS           loss 5.05 yen      loss 15.33 yen      7.52 yen   
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T